VY-FXN-01

N/A

Report date: 2025/01/26 15:11:07

Base Information

Drug NameVY-FXN-01
Drug Alias NameAAV-based gene therapy (Voyager/Neurocrine)VY-FXN-01
ClassificationBiologics
Mechanisms of ActionFrataxin, mitochondrial stimulants
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoyager Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVoyager Therapeutics IncNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A